Literature DB >> 14136244

THE GALACTOSE ELIMINATION CAPACITY IN RELATION TO CLINICAL AND LABORATORY FINDINGS IN PATIENTS WITH CIRRHOSIS.

N TYGSTRUP.   

Abstract

Entities:  

Keywords:  BILIRUBIN; BLOOD PROTEIN ELECTROPHORESIS; CARBOHYDRATE METABOLISM; GALACTOSE; LIVER CIRRHOSIS; LIVER FUNCTION TESTS; SERUM ALBUMIN; SERUM GLOBULINS; SULFOBROMOPHTHALEIN; THYMOL

Mesh：

Substances：

Year:  1964        PMID： 14136244     DOI： 10.1111/j.0954-6820.1964.tb00577.x

Source DB:  PubMed          Journal:  Acta Med Scand        ISSN： 0001-6101


× No keyword cloud information.
  9 in total

1.  Can intrahepatic shunting be measured?

Authors:  S Keiding
Journal:  Dig Dis Sci       Date:  1991-09       Impact factor: 3.199

2.  [Hepatic galactose elimination lapacity in chronic renal insufficiency (author's transl)].

Authors:  H Wernze; F Wagner
Journal:  Klin Wochenschr       Date:  1973-09-15

3.  The galactose elimination capacity and mortality in 781 Danish patients with newly-diagnosed liver cirrhosis: a cohort study.

Authors:  Peter Jepsen; Hendrik Vilstrup; Peter Ott; Susanne Keiding; Per K Andersen; Niels Tygstrup
Journal:  BMC Gastroenterol       Date:  2009-06-30       Impact factor: 3.067

4.  Hepatic ethanol elimination kinetics in patients with cirrhosis.

Authors:  Gitte Dam; Michael Sørensen; Ole Lajord Munk; Susanne Keiding
Journal:  Scand J Gastroenterol       Date:  2009       Impact factor: 2.423

5.  Impaired conversion of prednisone to prednisolone in patients with liver cirrhosis.

Authors:  S Madsbad; B Bjerregaard; J H Henriksen; E Juhl; H Kehlet
Journal:  Gut       Date:  1980-01       Impact factor: 23.059

6.  Prognostic value of (13)C-phenylalanine breath test on predicting survival in patients with chronic liver failure.

Authors:  I Gallardo-Wong; S Morán; G Rodríguez-Leal; B Castañeda-Romero; R Mera; J Poo; M Uribe; M Dehesa
Journal:  World J Gastroenterol       Date:  2007-09-14       Impact factor: 5.742

7.  [14C]Aminopyrine breath analysis and conventional biochemical tests as predictors of survival in cirrhosis.

Authors:  D A Henry; G Kitchingman; M J Langman
Journal:  Dig Dis Sci       Date:  1985-09       Impact factor: 3.199

8.  [Liver function of patients with arterial hypoxemia in chronic obstructive respiratory tract disease and the effect of nasal oxygen insufflation].

Authors:  G H Micklefield; D Schött; H D Kuntz; B May; W T Ulmer
Journal:  Klin Wochenschr       Date:  1989-08-17

9.  The soluble mannose receptor (sMR) is elevated in alcoholic liver disease and associated with disease severity, portal hypertension, and mortality in cirrhosis patients.

Authors:  Thomas Damgaard Sandahl; Sidsel Hyldgaard Støy; Tea Lund Laursen; Sidsel Rødgaard-Hansen; Holger Jon Møller; Søren Møller; Hendrik Vilstrup; Henning Grønbæk
Journal:  PLoS One       Date:  2017-12-13       Impact factor: 3.240
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.